Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Health Policy (Amsterdam, Netherlands)|September 28, 2016
Public reporting and the quality of care of German nursing homesAnnika Herr, Thu-Van Nguyen, Hendrik SchmitzUndersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|November 23, 2020
Platelet activation in rabbits with decompression sicknessPhuc Hong Cao, Bao Quoc Dang, Thu Van Nguyen, et al.Acta Oncologica (Stockholm, Sweden)|March 19, 2011
Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminomaThomas Zilli, Chantal Boudreau, Robert Doucet, et al.International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancerMichael Yassa, Bernard Fortin, Marie-Andrée Fortin, et al.Physiological Genomics|March 20, 2023
Impact of exercise on brain-bone marrow interactions in chronic stress: potential mechanisms preventing stress-induced hypertensionThu Van Nguyen, Ko Yamanaka, Keisuke Tomita, et al.Radiation Oncology (London, England)|September 24, 2013
Cervical necrosis after chemoradiation for cervical cancer: case series and literature reviewZiad Simon Fawaz, Maroie Barkati, Marie-Claude Beauchemin, et al.Cancer|August 26, 2010
Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancerThomas Zilli, Miguel Chagnon, Thu Van Nguyen, et al.Gynecologic Oncology|January 3, 2006
Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrencePatrick Petignat, Marjory Jolicoeur, Abdulaziz Alobaid, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancerDavid A Tiberi, Jean-François Carrier, Marie-Claude Beauchemin, et al.Cancer Epidemiology|November 19, 2011
The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancerGuila Delouya, Gabriel Kaufman, Marie-Pierre Sylvestre, et al.Pageof 4